The MLL recombinome of acute leukemias in 2017

Claus Meyer, Thomas Burmeister, Daniela Gröger, +66

Leukemia

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration

Inge M. Ambros, Peter F. Ambros, Sabine Strehl, +3

Cancer

Specific Chromosome AberrationTumoral PathologyY ChromosomesMalignant DiseaseMic2 Gene +13

The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister, +82

Leukemia

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott, +31

Blood

New insights to the MLL recombinome of acute leukemias

Claus Meyer, Eric Kowarz, Jörg Hofmann, +47

Leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyNew InsightsMedicine +3

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, +21

Blood

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

Dani Bercovich, Ithamar Ganmore, Linda M. Scott, +26

The Lancet

Down SyndromeHematological MalignancyAcute Lymphoblastic LeukaemiasMixed-phenotype Acute LeukemiaMalignant Blood Disorder +8

PHF6 mutations in T-cell acute lymphoblastic leukemia

Pieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, +30

Nature Genetics

Hematological MalignancyPhf6 MutationsMixed-phenotype Acute LeukemiaHematologyAdult T-cell Leukemia-lymphoma +1

The MLL recombinome of acute leukemias

Claus Meyer, Björn Schneider, Stephan M. Jakob, +33

Leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyMll RecombinomeMedicine +3

A novel putative tyrosine kinase receptor with oncogenic potential.

Johannes W.G. Janssen, Adriana Schulz, Ada C. M. Steenvoorden, +4

PubMed